Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VD, Yeast β-Glucan in Diabetes
NCT06861062Recruiting
- Sponsor
- Huazhong University of Science and Technology
- Start
- Apr 2025
- Primary completion
- Dec 2030
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of vitamin d and beta-glucans + saccharomyces cerevisiae in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Huazhong University of Science and Technology. Primary endpoints: Glycemic control at 24 months and Cardiovascular disease risk at 24 months. Started Apr 2025; status: recruiting.
02
Drugs
vitamin dbeta-glucans + saccharomyces cerevisiae
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06861062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06861062.